Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine is a synthetic adenosine analog that functions as an inhibitor of S-Adenosylhomocysteine (AdoHcy) hydrolase. This enzyme plays a crucial role in regulating adenosylmethionine-dependent transmethylations by hydrolyzing AdoHcy into homocysteine and adenosine. The compound's unique binding mode to AdoHcy hydrolase has been characterized, involving interactions from two protein monomers and a catalytic water molecule. While primarily studied in a research context, its inhibitory action on AdoHcy hydrolase suggests potential relevance in conditions such as Hypermethioninemia and disorders related to methionine metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine.